Previous research has predominantly focused on the role of FAM3A in insulin resistance, gluconeogenesis, lipogenesis, hypertension, chondrocyte apoptosis, and cardiovascular hypertrophy (Chen et al. 2020; Xiang et al. 2020; Yan et al. 2019; Yang et al. 2020). This evidence concerns the gene FAM3A and hypertensive disorder.